Back

Differential effects of beta-blockers on conduit and microvascular endothelial function assessed by FMD and RHI

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Hypertension clinical aspects Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tomohiro Ueda

Ohchi Principal Hospital, Shimane (Japan)

4 More presentations in this session

Presentation thumbnail
Prevalence of hypertension and blood pressure control using ambulatory blood pressure monitoring (ABPM) criteria. The Colombian GLADIATOR ABPM registry.
Doctor A. Sotomayor (Cali, CO)
Abstract Slides Video
Presentation thumbnail
Percutaneous treatment of chronic renal artery occlusions in pediatric nephrovascular hypertension. A case series
Doctor L. Mircoli (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Low-grade inflammation mediates the association between albuminuria and vision-threatening diabetic retinopathy in US adults with and without elevated blood pressure
Doctor E. Enimah (Kuopio, FI)
Abstract Slides Video
Presentation thumbnail
Vascular stiffness is deteriorated in non-dipper or morning surge hypertensive patient even after adequate blood pressure control.
Professor C. Park (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension clinical aspects

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Marked impairment of endothelium-dependent digital vasodilatations in patients with microvascular angina compared with those with vasospastic angina
2 September 2019
thumbnail
Congress Presentation
Do alpha-adrenergic blockers really increase the risk of poor cardiovascular outcomes? An across-the-board meta-analysis
30 June 2021
thumbnail
Congress Presentation
Comparison of baseline non- invasive hemodynamic evaluation among patients with advanced conduction disorders based on high Vs. low peripheral vascular resistance reserve
25 March 2023
thumbnail
Congress Presentation
H1 antagonist loratadine improves microcirculation in reperfused myocardial infarction
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources